Harvard Women's Health Watch

In the journals: Study elucidates health risks for DES daughters

The health risks of women whose mothers were given the drug DES have been documented in a follow-up study.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In